SCHEMBL19969853

SCHEMBL19969853

CCCOCc1c(C)n(CC(F)F)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 2/20 0.42
▸ KDM4E B2RXH2 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ LMNA P02545 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ CNR1 P21554 2/20 0.34
▸ CNR2 P34972 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ XBP1 P17861 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ BACE1 P56817 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19068171 0.84 HTR3A (0.42) HTR3AKDM4ESMN1; SMN2ALDH1A1TDP1
SCHEMBL19969811 0.73 HTR3A (0.39) HTR3AKDM4ESMN1; SMN2ALDH1A1TDP1
SCHEMBL19969987 0.71 HTR3A (0.39) HTR3AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL17170668 0.68 HTR3A (0.57) HTR3AALDH1A1LMNAMAPTCNR1
SCHEMBL5328061 0.67 KDM4E (0.47) KDM4ESMN1; SMN2ALDH1A1TDP1LMNA
SCHEMBL17176479 0.67 HTR3A (0.59) HTR3ASMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL11681291 0.64 ALDH1A1 (0.53) KDM4ESMN1; SMN2ALDH1A1TDP1MAPT
Ammonia Solution, Strong SCHEMBL27949259 0.62 ALDH1A1 (0.52) KDM4ESMN1; SMN2ALDH1A1TDP1MAPT
SCHEMBL31081068 0.62 LDHA (0.36) KDM4ESMN1; SMN2ALDH1A1TDP1MAPT
SCHEMBL10654147 0.62 PGR (0.55) KDM4EALDH1A1TDP1LMNACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072758-A1 5HT3 RECEPTOR ANTAGONISTS TAKEDA CALIFORNIA, INC. 2018-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072758-A1 5HT3 RECEPTOR ANTAGONISTS HTR3A, HTR3B, HTR5A HTR3A 1/4885KDM4E 3871/4885SMN1; SMN2 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback